Fusion Investment Group’s Bristol-Myers Squibb BMY Stock Holding History

Fusion Investment Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$866K	Buy	12,569 +18	+0.1%	+$1.19K	2.32%	12
2015 Q3	$743K	Sell	12,551 -881	-7%	-$55.9K	1.76%	17
2015 Q2	$894K	Sell	13,432 -292	-2%	-$19.2K	0.69%	28
2015 Q1	$885K	Sell	13,724 -874	-6%	-$54.7K	0.71%	27
2014 Q4	$862K	Buy	14,598 +7,001	+92%	+$395K	0.73%	24
2014 Q3	$389K	Sell	7,597 -98	-1%	-$4.89K	0.34%	45
2014 Q2	$373K	Sell	7,695 -696	-8%	-$34.3K	0.32%	54
2014 Q1	$437K	Buy	8,391 +750	+10%	+$39.9K	0.44%	38
2013 Q4	$406K	Buy	+7,641	New	+$389K	0.3%	76

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fusion Investment Group's BMY Position: Q4 2015 in Review

Fusion Investment Group increased its Bristol-Myers Squibb (BMY) stake by 0.14% in Q4 2015, buying an estimated $1.19K and bringing the position to 12,569 shares worth $866K. The position accounts for 2.32% of the portfolio, ranked #12.

Fusion Investment Group first reported a position in BMY in Q4 2013 and has held it in 9 quarters since. The position peaked at $894K in Q2 2015. 1,535 funds tracked by Wall St. Rank hold BMY as of Q4 2015.

Fusion Investment Group held 12,569 shares of Bristol-Myers Squibb worth $866K as of Q4 2015.
Fusion Investment Group bought 18 Bristol-Myers Squibb shares in Q4 2015, an estimated $1.19K.
Bristol-Myers Squibb made up 2.32% of Fusion Investment Group's portfolio in Q4 2015, its #12 holding.
Fusion Investment Group first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 9 quarters since.
Fusion Investment Group's Bristol-Myers Squibb position peaked at $894K in Q2 2015.
1,535 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2015.

Based on Fusion Investment Group's 13F filing for Q4 2015, filed 16 Feb 2016.